DS
TAK icon

DRW Securities’s Takeda Pharmaceutical TAK Stock Holding History

DRW Securities’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Buy
+22,425
New +$371K 0.01% 525
2025
Q4 		– Sell
-10,416
Closed -$153K – 1689
2025
Q3 		$153K Buy
+10,416
New +$155K ﹤0.01% 1130

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

DRW Securities's TAK Position: Q2 2026 in Review

DRW Securities opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 22,425 shares worth $359K. The stake represents 0.01% of the portfolio and ranks #525 among its holdings. This is a return to the name: DRW Securities previously reported a position in TAK as recently as Q3 2025.

DRW Securities first reported a position in TAK in Q3 2025 and has held it in 2 quarters since. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • DRW Securities held 22,425 shares of Takeda Pharmaceutical worth $359K as of Q2 2026.
  • Takeda Pharmaceutical was a new DRW Securities position in Q2 2026.
  • Takeda Pharmaceutical made up 0.01% of DRW Securities's portfolio in Q2 2026, its #525 holding.
  • DRW Securities first reported a position in Takeda Pharmaceutical in Q3 2025 and has held it in 2 quarters since.
  • 379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.